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Summary 
Naive T  cells in the periphery mainly secrete interleukin (IL) 2 upon activation. After stimula- 
tion in the presence of appropriate costimulators, both CD4 + and CD8 + T  cells  differentiate 
into  effector cells  secreting distinct T  helper (Th)  l- and Th2-1ike cytokine patterns.  Subse- 
quent to differentiation, both CD4 + (Thl and Th2) and CD8 + (TC1 and TC2) cells are stable 
and cannot be induced to differentiate into the opposite pattern or revert to the naive cytokine 
secretion pattern. We now show that IL-4 caused committed TC1 bulk populations or clones 
to lose the ability to synthesize IL-2. The cells retained the ability to secrete interferon (IFN) % 
granulocyte/macrophage colony-stimulating factor, and tumor necrosis factor, did not synthe- 
size any Th2 cytokines, and did not alter cell surface marker expression. IL-4 rapidly inhibited 
IL-2--synthesizing ability in the absence or presence of antigen-presenting cells,  thus  demon- 
strating that IL-4 acted direcdy on TC1  cells.  The defect in IL-2 synthesis could not be re- 
versed by subsequent stimulation with potent antigen-presenting cells in the presence of IL-2 
and anti-IL-4, or with anti-CD3 plus anti-CD28 antibodies. Both IL-2  + and IL-2- TC1  cells 
were  strongly cytotoxic toward  allogeneic  but  not  syngeneic  targets.  However,  IL-2- TC1 
cells were unable to proliferate unless exogenous IL-2 was provided. TC1  cells that lose IL-2 
synthesis but retain IFN-'y synthesis and cytotoxicity may be similar to the "anergic" cells in- 
duced by stimulation  of CD4 + or CD8 §  cells  in the  absence of costimulators.  These results 
suggest that during a mixed type 1/type 2 response in vivo, IL-4 may induce the IL-2  § TC1 
-~ IL-2- TC1 conversion, and thus curtail the expansion of the TC1 response without impair- 
ing short-term effector function. 
F 
unctionally different subsets of CD4 + and CD8 + cells 
have important regulatory and effector roles in immune 
responses. Based on the cytokine synthesis patterns of long- 
term clones, CD4 + T  cells were classified  into Thl  (IL-2, 
IFN-~/and TNF-[3) and Th2 (IL-4, IL-5, IL-6, IL-10, and 
IL-13) (1-3). Many of the functions ofT cells are mediated 
by cytokines that are secreted upon their stimulation.  Thl 
cells,  through  their production of IFN-~ and TNF-[3, in- 
duce delayed-type hypersensitivity and microbicidal activ- 
ity in macrophages (cellular immunity), whereas Th2 cells 
secrete  cytokines that  help B  cells  become antibody-pro- 
ducing  cells  (humoral immunity)  and  enhance  allergy (3). 
Distinct  cytokine-secreting subsets  of CD8 +  T  cells  have 
also been identified (4-7). Cytokine patterns of CD8 + sub- 
sets are similar to their CD4 + counterparts: TC1 cells secrete 
IL-2 and  IFN-% and  TC2  cells  secrete  IL-4,  IL-5,  IL-6, 
and  IL-10.  The  existence  of subsets  of both  CD4 +  and 
CD8 + T  ceils in vivo has been demonstrated in various in- 
fections (8-13). 
Cytokines are the major factors that determine the  dif- 
ferentiation of precursor T  cells. IL-12, TGF-[3, and IFN-~/ 
induce the differentiation of naive CD4 + T  cells into Thl 
but not Th2 cells (14-17), whereas IL-4 is essential for dif- 
ferentiation into Th2 cells and inhibits development of Thl 
cells  (18,  19).  IFN-',/ and IL-4 also induce the differentia- 
tion of naive CD8 + T  cells into TC1 and TC2 phenotypes, 
respectively (4-6), and IL-12 enhances the cytotoxicity and 
IFN-~/production  of CD8 +  cells  (20).  Cytokine-directed 
differentiation may be due to a combination of inhibitory 
and enhancing  effects on the  two arms of the  differentia- 
tion pathway. 
Cytokines secreted by Thl  and Th2 cells also cross-reg- 
ulate the proliferation or cytokine secretion of committed 
cells of the opposite subset (3).  IL-10 secreted by Th2 cells 
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IFN-~/  secreted by  Thl  cells inhibits  the  proliferation of 
Th2 but not Thl  cells (23, 24). Less has been known about 
the influence ofcytokines on the proliferation and cytokine 
secretion of committed CD8 + effector cells. 
Subsequent to differentiation, effector T  cells maintain a 
relatively stable cytokine secretion pattern, as they rarely, if 
ever, change into the opposite phenotype or revert to their 
precursor state.  However,  some alterations have  been  de- 
scribed.  Th0  cells (secreting Thl  and  Th2  cytokines) be- 
come more Thl-  or Th2-1ike in response to different cy- 
tokines (25, 26). Stimulation of Th0 ceils with anti-CD3 in 
the absence ofcostimulators induced a shift to a more Th2- 
like phenotype (25). In the absence of appropriate costimu- 
lators, for example, stimulation with antigen on fixed APC, 
both CD4 + Thl and CD8 + TC1  cells lose the ability to syn- 
thesize  IL-2  and  proliferate  (27-29).  This  "anergic"  state 
was reversed when Thl  cells were subsequently stimulated 
with allogeneic non-T cells (30), IL-2, or IL-4 (31, 32), al- 
though reversal was not observed in another study (33). 
We now  show  that,  in addition to  the well-established 
effects of IL-4 on naive T  cells, IL-4 inhibits the ability of 
differentiated CD8 + TC1  cells to synthesize IL-2. This was 
not reversed by IL-2 during or after IL-4 treatment. Loss of 
the ability to synthesize IL-2 did not impair TC1 functional 
capability,  as  both  the  IL-2-secreting  (IL-2  +)  and  the 
IL-2-nonsecreting  (IL-2-)  CD8 +  TC1  cells were  highly 
cytolytic and  secreted normal  amounts  of other TC1  cy- 
tokines (IFN-y, GM-CSF, and TNF).  However, the sub- 
sequent proliferation oflL-2- TC1  cells became dependent 
on exogenous IL-2, suggesting that this may be another ex- 
ample of cross-inhibition of the type 1 and type 2 cytokine 
patterns. 
Materials and Methods 
Mice.  Female  C57BL/6  mice,  4-6-wk  old,  were  obtained 
from The Jackson Laboratory (Bar Harbor, ME). Mice were main- 
tained in the  Health  Sciences Laboratory Animal Services (Ed- 
monton, Alberta, Canada) in accordance with the the guidelines 
of the Canadian Council on Animal Care. 
Cell Lines.  The  mouse hybrid B  cell line M12.4.1  (34)  ex- 
pressing  H-2  a  was  obtained  from  Dr.  L.  Glimcher. J774A.1 
(mouse macrophage cell line expressing H-2d), P815,  EL4,  and 
WEHI-164-13  cell lines  were  obtained from  American  Type 
Culture Collection (Rockville, MD). 
Cytokines,  Antibodies,  and Reagents.  Mouse  recombinant IL-2 
was expressed in Escherichia coli (35) and used as a partially purified 
preparation at 2.5  ng/ml.  Recombinant mouse  IL-4 and IL-12 
were expressed in COS cells and used as a dilution of COS trans- 
fection  supernatants  (36).  Hamster anti-mouse CD28  antibody 
clone 37.51  (37) was obtained from Dr. James P. Allison. Anti- 
IL-4 and anti-CD28 antibodies were purified on a protein G col- 
umn  from the supernatants of llBll  (38)  and 37.51  cell lines. 
Con A  was obtained from Pharmacia  (Uppsala, Sweden).  Fetal 
bovine  serum  (FBS) 1 was  obtained from  Hyclone Laboratories 
i Abbreviation used in this paper: FBS, fetal bovine serum. 
Inc.,  (Logan,  UT). Biotinylated anti-mouse Pgpl  (CD44,  clone 
IM7), Ly3-PE (anti-CD8[3, clone 53-5.8), and NKI.I-PE (clone 
PK136)  were  obtained  from  PharMingen  (San  Diego,  CA). 
Streptavidin-FITC was  obtained from  Southern  Biotechnology 
Associates  (Birmingham,  AL).  Rabbit  anti-hamster  IgG-FITC 
was  obtained from Jackson ImmunolLesearch Laboratories, Inc. 
(West Grove, PA). R.at anti-mouse Ly2-FITC and Ly2-PE (anti- 
CD8o~, clone YTS 169.4) were obtained from Cedarlane Labora- 
tories Ltd. (Homby, Ontario, Canada). 
Ceil Cultures.  C57BL/6  CD8 + T  cells were enriched by re- 
moval of B  cells, CD4 + T  cells, and macrophages on rat T  col- 
umns (Biotex, Edmonton, Alberta, Canada). Splenocytes (150  ￿ 
10 6)  were  incubated with a rat anti-mouse CD4 antibody (clone 
YTS  191.1)  and  loaded  onto  glass bead  columns  coated  with 
sheep anti-rat Ig (cross-reactive with mouse Ig). Cells that passed 
through the column were 80-90% CD8 + by FACScan  ~~ analysis. 
In some experiments, CD8 + T cells were further purified by sort- 
ing on a cell sorter (EPICS Elite; Coulter Corp., Hialeah, FL) af- 
ter staining the cells with rat anti-mouse Ly2-FITC (clone YTS 
169.4).  C57BL/6 CD8 § T cells (H-2  b, 103/well)  were stimulated 
with 104 cells/well of irradiated (10,000  rad) allogeneic APC lines 
M12.4.1  (H-2  a,  B  cell lymphoma  [34])  and J774  (H-2  d,  mac- 
rophage) in 96-well tissue culture plates in 200 ILl of RPMI plus 
8% FBS in the presence of various cytokines. IL-2 was added at 
2.5 ng/ml, and, where appropriate, anti-IL-4 (11Bll) at 25  [xg/ 
ml and IL-4 at 10 ng/ml were added unless otherwise mentioned. 
Media were  changed  every third day after splitting cultures as 
necessary. 
For purification of CD4 § T  cells, C57BL/6  splenocytes were 
incubated  with  a  rat  anti-mouse  CD8  antibody  (clone  YTS 
169.4)  and processed as mentioned above for CD8 + T cell purifi- 
cation. 
Cytokine secretion was determined after Con A  stimulation 
(5 p~g/ml) ofeffector cells (106/ml) in 200 p~l of RPMI 1640 plus 
8% FBS. Arithmetic means and SD of triplicate cultures were cal- 
culated. 
Generation of Long-Term T Cell Clones.  C57BL/6 CD8 + T cells 
were  cloned  by  limiting dilution  in  the  presence  of cytokine 
combinations favoring differentiation into the TC1  (IL-2 +  IL- 
l2 +  anti-lL-4) phenotype as described above. Limiting dilution 
cloning was  carried out by stimulating the  C57BL/6  CD8 +  T 
cells  (1,000  cells/well to  0.5  cell/well) with irradiated M12.4.1 
cells  (5  ￿  104/well)  in  96-well round-bottomed tissue  culture 
plates in 200  ILl of KPMI  1640  plus 8% FBS. Every third day, 
100 p.1 of media was changed. 
CytokineAssays.  Cytokines  produced  in  the  supernatants 
were  measured by ELISA (39).  The  following antibodies were 
used:  R4-6A2  (ATCC  HB170)  and  XMG1.2-biotin  (2)  for 
IFN-~; BVD4-1D11  and BVD6-24G2-biotin (PharMingen) for 
IL-4; TP,  FK5  (40)  and TP,  FK4-biotin (PharMingen)  for IL-5; 
JES6-1A12  and JES6-5H4-biotin  (PharMingen)  for  IL-2;  8F8 
and 43D11-biotin (41) for IL-3; SXC2 and SXCl-biotin (42) for 
IL-10; 35E10 and 22E9-biotin for GM-CSF; and MP5-20F3 and 
MP5-32C11-biotin (PharMingen) for IL-6. TNF was assayed on 
WEHI-164.13  cells as described (43),  except that the  assay was 
carried out in the presence of saturating (5  ng/ml)  amounts  of 
IFN-~/. 
Thymidine  Incorporation.  IL-2- or IL-2  + TC1  cells were gen- 
erated by stimulating effector TC1  cells on day 6 with allogeneic 
J774A.1  cells in the presence or absence of IL-4 for another 6 d. 
On  day 12,  the proliferative capability of allospecific IL-2  + and 
IL-2- CD8 + TC1  cells was assessed by analyzing the incorpora- 
tion of labeled thymidine every day for 4 d. TC1  cells (1.1  ￿  104 
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cells (5  ￿  104/ml) in 96-well flat-bottomed tissue culture plates 
in 200 I.tl RPMI 1640 plus 8% FBS in the presence or absence of 
various growth factors. Radiolabeled thymidine was added (1 ~Ci/ 
well) at the same time or after every 24 h. Cells were then har- 
vested 24 h after the thymidine pulse, and radioactive  incorpora- 
tion was determined by liquid scintillation counting. 
Cytotoxicity Assays.  6 d after the stimulation of naive CD8 + 
T cells with M12.4.1  cells in the presence of IL-2 plus anti-IL-4, 
aliquots of the cells were stimulated for another 6 d with M12.4.1 
cells in the presence of (a) IL-2 plus anti-IL-4, (b) IL-2 plus IL-12 
plus anti-IL-4, or (c) IL-2 plus IL-4. The resulting IL-2  + and IL- 
2- TCI  cells were then analyzed  for their cytolytic activity  to- 
ward labeled P815  (allogeneic)  and EL4  (syngeneic)  tumor cell 
lines.  Target cells were  radiolabeled  by incubation of 107  cells 
with 100 I.LCi of S*Cr in 50 b~l medium for 45 rain. After thor- 
ough washing,  various  ratios  of effectors to targets were cocul- 
tured for 4  h  in 96-well round-bottomed tissue  culture plates. 
R.adioactivity was detected in the supernatants  by gamma count- 
ing. The percentage of cytotoxicity was calculated using the fol- 
lowing formula: 
(cpm experimental -  cpm spontaneous)/ 
(cpm total  -  cpm spontaneous)  ￿  100. 
Flow CytometryAnalysis.  Normal  C57BL/6  splenocytes  or 
effector IL-2 + or IL-2- TC1 cells were washed and incubated on 
ice (106 cells in 50 b~l R.PMI  1640 plus 1% FBS) with the follow- 
ing antibodies:  anti-CD8o~-PE, anti-CD8o~-FITC, anti-CD813- 
PE,  anti-NKl.1-PE,  biotin-anti-rnouse CD44,  and  hamster 
anti-mouse CD28. CD44 and CD28 expression were revealed by 
second staining with streptavidin-FITC and rabbit anti-hamster 
IgG-FITC,  respectively.  Each  incubation lasted  30  rain,  after 
which  cells were  thoroughly washed.  Cells  were  fixed  in  1% 
formaldehyde  in  PBS  and  analyzed  on  a  FACScan  ~  (Becton 
Dickinson & Co., Mountain View, CA). 
Results 
IL-4 Inhibits the Subsequent Ability of CD8 + TC1  Cells to 
Secrete IL-2 without Abrogating IFN-% GM-CSF, and TNF 
Synthesis or Altering Expression of Cell Surface Markers.  Effec- 
tor CD8 + TC1 cells were established by stimulating freshly 
isolated splenic CD8 + T  cells with allogeneic M12.4.1 cells 
in the presence of IL-2 and anti-IL-4 antibodies. After 6 d 
in culture, the resulting TC1 effectors were stimulated with 
M12.4.1  cells in growth media containing IL-2 and either 
IL-4 or anti-IL-4. After another 6  d, cells were harvested, 
washed, and stimulated with Con A  for 24 h.  Fig.  1 dem- 
onstrates that  effectors  generated in the presence of anti- 
IL-4 secrete 1L-2, IFN-y, GM-CSF, and TNF, whereas an 
aliquot of the same culture stimulated on day 6 in the pres- 
ence  of IL-4  lost  the  subsequent  ability to  secrete  IL-2 
when stimulated with Con A  on day 12.  The ability to se- 
crete  IFN-y,  GM-CSF,  and  TNF  was  maintained.  In  a 
large number of experiments, IFN-',/synthesis was moder- 
ately increased or decreased after IL-4 treatment, but never 
strongly reduced  or  lost.  Stimulation in  the  presence  of 
IL-4 did not result in a shift toward the TC2 phenotype, as 
these cells did not secrete IL-4, IL-5, or IL-6. Low levels of 
IL-10 were synthesized by TC1  cells,  consistent with pre- 
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Figure 1.  IL-4 selectively impairs the subsequent ability of committed 
CD8 + TC1  cells to  secrete IL-2 on restimulation. C57BL/6 splenic 
CD8 + T cells (103/well) were stimulated with allogeneic M12.4.1 cells 
(104/well) in the presence oflL-2 plus anti-IL-4. On day 6, the resulting 
effector TC1 cells  were then split and restimulated  with M12.4.1 cells  in 
the presence of either IL-2 plus anti-IL-4 or IL-2 plus IL-4 for another 6 d. 
On day 12, cells were thoroughly washed and stimulated (106/ml) with 
Con A (5 I*g/ml) for 24 h. Cytokines  were measured in the supematants. 
vious findings (4),  and IL-4 treatment did not alter these 
levels. Both  IL-2  +  and IL-2-  TC1  cells expressed similar 
levels of CD8o~,  CD8~,  CD28,  and CD44 and remained 
NKI.1-  (Fig. 2).  Thus, IL-4-treated TC1  cells selectively 
lost  the  ability to  subsequently secrete  IL-2,  without any 
other detectable alterations. This occurred even in the pres- 
ence of exogenous IL-2. 
IL-4 Induced the Loss of lL-2-synthesizing Ability during 
Stimulation of TC1 Cells by Either B Cell or Macrophage APC 
Lines.  To determine whether the loss of IL-2--synthesiz- 
ing ability occurred under different stimulation conditions, 
we established allospecific TC1  cells by primary allostimu- 
lation with M12.4.1  (a  B  cell line)  or J774A1  (a  macro- 
phage cell line) in the presence oflL-2, IL-12, and anti-IL-4 
antibodies. When these established TC1  cells were restim- 
ulated with the same APC, IL-4 induced both TC1 popu- 
lations to lose the subsequent ability to synthesize IL-2 (Fig. 
3).  Synthesis of other cytokines (IFN-y and IL-4) was not 
aftbcted. 
IL-4-induced Loss of lL-2 Synthesis  in  Clones of CD8  + 
TC1 Cells.  To rule out the possibility that IL-4-induced 
generation  of  IL-2-  cells  was  a  result  of selective  out- 
growth of a minor population of cells within the bulk cul- 
ture, we generated clones of TCI  cells in the presence of 
anti-IL-4. After their commitment into a TC1 phenotype, 
each  clone was  split into growth  media containing either 
anti-IL-4 or IL-4 and stimulated with M12.4.1 cells for an- 
other 6 d. Fig. 4 demonstrates that 8 of the 10 clones gen- 
erated in the presence of anti-IL-4 secreted IL-2, whereas 
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Figure  2.  IL-2  +  and  IL-2-  TC1  cells express  similar  surface  antigens. 
Normal C57BL/6 splenic  CD8 + T  cells were stimulated with allogeneic 
J774A.1  cells in the presence oflL-2 plus IL-12 plus anti-IL-4. On day 6, 
the resulting effector TC1 cells were then washed, split, and cultured with 
either IL-2 plus anti-IL-4 or IL-2 plus IL-4 for another 6 d. On day  12, 
IL-2  + and IL-2- TC1  cells were washed, stained  with various antibodies, 
and analyzed by flow cytometry. 
all  the  clones  secreted  IFN-y  and no  IL-4  or IL-5.  How- 
ever, when cultured in the presence of IL-4, all clones con- 
tinued  to secrete  IFN-y  but lost their ability to synthesize 
IL-2.  Furthermore,  neither  the  IL-2 +  nor  IL-2-  cells  se- 
creted IL-4 or IL-5 on subsequent stimulation showing that 
there was no switch  to the  TC2  or TC0  phenotypes  (Fig. 
4).  These  results  demonstrate  that the loss of the ability to 
synthesize IL-2 occurs within clones of TC1  cells,  suggest- 
ing that there is a direct  IL-2 + TC1  -+  IL-2-  TC1  transi- 
tion. 
IL-4 Acts on  TC1  Cells to Induce Differentiation  into  the 
IL-2- Phenotype.  In the experiments shown in Figs.  1 and 
2, IL-4 may have acted directly on T  cells, or indirectly by 
altering the  antigen-presenting  or costimulatory properties 
of the  APC.  To  distinguish  between  these  possibilities, 
freshly isolated splenic  CD8 + T  cells were stimulated with 
Figure  3.  Inhibition  of IL-2  synthesis  on  resfmulation  occurs  when 
TC1  cells are  stimulated with either B cell or macrophage APC lines  in 
the presence of IL-4. Allospecific  TC1  cells were generated by stimulat- 
ing splenic  CD8 + T  cells with either M12.4.1  (B cell) or J774A.1  (mac- 
rophage) cells in the presence oflL-2 plus IL-12 plus anti-IL-4. 6 d later, 
resulting TC1 cells were split into either IL-2 plus anti-lL-4 or IL-2 plus 
IL-4 and  restimulated with the  same APC  line.  On  day  12,  TC1  cells 
were washed and stimulated (106/ml)  with Con A  (5  p+g/ml). Supema- 
tants were collected  24 h later, and cytokines were measured. 
irradiated allogeneic J774 cells in the presence  of IL-2 plus 
IL-12 plus anti-IL-4  for 7  d. The resulting TC1  cells were 
then cultured in either IL-2 plus anti-IL-4 or IL-2 plus IL-4 
for 6  more days in the presence  or absence  of fresh  irradi- 
ated APC.  On day 13,  cells were washed and restimulated 
with  Con A  for 24 h  for cytokine secretion.  Fig.  5  clearly 
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Figure  4.  Clones ofCD8 + TC1  cells lose  the  capacity  to secrete  IL-2 
but not IFN-3' when stimulated in the presence of IL-4.  CD8  + clones 
were generated by limiting dilution ofputified C57BL/6 CD8 + T cells in 
the presence of irradiated  M12.4.1  cells under conditions favoring differ+ 
entiation into TC1  cells (IL-2 plus anti-IL-4). On day 6, each clone was 
stimulated with M12.4.1  cells for another 6 d in the presence of the same 
cytokine combinations. Aliquots of each  clone were split on day  12 and 
restimulated  with M12.4.1  cells in the presence of either IL-2 plus anti- 
IL-4 or IL-2 plus IL-4. 6 d later,  cells were thoroughly washed and stim- 
ulated  with Con A for 24 h for cytokine secretion. 
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Figure 5.  Inhibition of IL-2~ynthesizing ability occurs when TC 1 cells 
are incubated with IL-4 in the absence ofAPC. Allospecific TC1 cells were 
generated by stimulating C57BL/6 CD8 + T  cells  with J774  cells in the 
presence of IL-2 plus IL-12 plus anti-IL-4.  On day 7,  TC1  cells were 
washed and cultured with either IL-2 plus anti-IL-4 or IL-2 plus IL-4 in 
the presence or absence of irradiated allogeneic M12.4.1 APC for another 
6 d. On day 12, cells were washed and stimulated with Con A for cyto- 
kine estimation as mentioned in Fig. 1. 
demonstrates  that,  even in  the  absence  of APC,  IL-4 im- 
pairs  the  subsequent  IL-2--synthesizing  capacity  of TC1 
cells.  Thus,  IL-4 appears to act directly  on  TC1  cells.  To 
determine  the  kinetics  of IL-4-induced  toss of IL-2-syn- 
thesizing  ability,  we incubated  differentiated  TC1  cells on 
day 7  with  IL-4 in  the  absence  of APC.  Cells were  then 
harvested  at  the  indicated  intervals  and  stimulated  with 
Con  A  for 24  h  to  determine  cytokine  secretion.  Fig.  6 
demonstrates  that  IL-2-synthesizing  ability  was  substan- 
tially inhibited  even after 3  h  of incubation  with  IL-4 and 
was totally  abrogated by  12  h.  IL-4 was most  effective at 
causing loss of IL-2 synthesis when  added during  the pre- 
culture  of TC1  cells.  When  IL-4 was  added  only during 
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Figure 6.  Abrogation oflL-2 synthesis occurs rapidly within 24 h oflL-4 
treatment. Allospecific TC1  cells  were generated by stimulating normal 
splenic CD8 + T  cells with allogeneic J774  cells in the presence of IL-2 
plus IL-12 plus anti-IL-4. On day 7, cultures were washed and incubated 
with IL-2 in the presence or absence oflL-4 for various times. After each 
incubation, cells  were washed thoroughly and stimulated (106/ml)  with 
Con A (5 ~zg/ml) for 24 h for cytokine synthesis. 
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Figure 7.  IL-4 does not abrogate IL-2 synthesis during short-term Con 
A activation ofcornmitted CD8 + TC1 cells. Allospecific IL-2  + and IL-2- 
TC1  cells were generated as mentioned in Fig.  1. On day 12, cells were 
thoroughly washed and stimulated with Con A for 24 h  in the presence 
or absence of IL-4. Cytokines were measured in the 24-h supematants. 
the final Con A  stimulation  of IL-2 §  TC1  cells,  IL-2 syn- 
thesis was partially inhibited but not abrogated (Fig. 7). 
IL-4-induced  Loss  of lL-2  Synthesis  by  TC1  Cells  Is  Irre- 
versible.  To  determine  whether  the  IL-4-induced loss  of 
the ability of TC1  cells to secrete IL-2 was a transient phe- 
nomenon,  IL-2 §  or  IL-2-  TC1  cells  were  generated  by 
stimulating  effector  TC1  cells  on  day  6  with  allogeneic 
M12.4.1  cells  in  the  presence  or  absence  of IL-4  for an- 
other 6  d.  On day 12,  the resulting IL-2- TC1  cells were 
split  into  growth  conditions  containing  either  IL-2  plus 
anti-IL-4  or  IL-2  plus  IL-4  and  were  stimulated  with 
allo AP( 
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Figure 8.  IL-4-induced inhibition of IL-2 synthesis by committed TC1 
cells is irreversible. Normal C57BL/6 splenic CD8 + T  cells were stimu- 
lated with allogeneic M12.4.1 cells in the presence oflL-2 plus IL-12 plus 
anti-lL-4. On day 6, the resulting effector TC1 cells were split and stim- 
ulated with M12.4.1  cells  in IL-4 or anti-lL-4.  On day  12,  aliquots of 
IL-2- TC1 cells (IL-2 plus IL-4 from days 6 to 12) were again stimulated 
in IL-2 plus 1L-4 or washed and stimulated in IL-2 plus anti-IL-4. IL-2 + 
TC1 cells (IL-2 plus anti-IL-4 from days 6 to 12) were restimulated in the 
same growth medium. On day  18,  cells  were  harvested and stimulated 
(106/ml) with Con A (5 I~g/ml) for 24 h for cytokine secretion. IL2  ng/ml 
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Figure 9.  Stimulation oflL-2  TC1 cells in the presence ofanti-CD28 
does not reverse the IL-4--induced  loss oflL-2 synthesis. Normal C57BL/6 
splenic CD8 + T cells  were stimulated with irradiated allogeneic  J774 ceils 
in the presence of IL-2 plus IL-12 plus anti-IL-4. On day 6, the resulting 
effector TCl cells were washed and cultured with either IL-2 plus anti- 
IL-4 or IL-2 plus IL-4.3 d later (day 9), cells were washed and stinmlated 
(10~'/ml) with plate-bound anti-CD3  (10 fxg/rnt) in the presence or ab- 
sence of  plate-bound anti-CD28 (10 b~g/ml). Supernatants were collected 
after 24 and 48 h for cytokine measurement. 
M12.4.1  cells for another 6  d.  On day  18,  cells were  har- 
vested and stimulated with Con A  for 24 h for cytokine se- 
cretion. TC1  cells that were continually grown in the pres- 
ence of anti-IL-4 secreted substantial amounts of both IL-2 
and  IFN-y  (Fig.  8),  whereas  the  cells grown  in  the pres- 
ence of IL-4 from days 6 to 18 lost their capacity to secrete 
IL-2 while retaining their IFN-y-producing capacity. IL-2 
secretion  was  not  restored  if the  IL-4-treated TC1  cells 
were  stimulated with  alloantigen in  the  presence  of IL-2 
plus anti-IL-4 from days 12 to 18. 
After  induction  of the  IL-2-  phenotype,  we  also  at- 
tempted to restore IL-2 synthesis by stimulation with plate- 
bound  anti-CD3  and  anti-CD28  antibodies.  Fig.  9  shows 
that  anti-IL-4-pretreated  TC1  cells  produced  substantial 
amounts  of IL-2, and,  in this experiment, IL-4-pretreated 
ceils produced a small amount  of IL-2 at 24 but not 48 h. 
Anti-CD28  costimulation caused  a  fourfold  enhancement 
of IL-2 secretion by both  cell populations at 24  h.  How- 
ever,  the  lL-4-pretreated TCl  ceils still produced  16-fold 
less IL-2 than controls. At 48 h, the control cultures main- 
taiued similar levels of IL-2, whereas  no  IL-2 was  detect- 
able in IL-4-pretreated cultures even with CD28  costimu- 
lation. Thus,  in these experiments as well as others (results 
not  shown),  we  have  been  unable  to  reverse  the  IL-4- 
induced defect in IL-2-producing capacity of TC1  cells. 
CD8 + TC1  Cells Are More Susceptible  than  CD4 + Till 
Cells to IL-4-induced Loss of lL-2 Synthesis.  As  long-term 
CD4 + clones can  sometimes selectively lose the ability to 
synthesize  IL-2  (Mosmann,  T.,  unpublished  observations), 
we tested whether IL-4 could also contribute to this effect. 
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Figure 10.  CD8 + TC1 cells require less IL-4 than CD4 + Thl cells for 
inhibition oflL-2 synthesis. Allospecific  CD4 + Thl and CD8 + TC1 cells 
were generated by stimulating normal splenic C57BL/6 CD4 + or CD8 + 
T cells with allogeneic M12.4.1 cells in the presence of ILh2 plus IL-12 
plus anti-/L-4 for 7 d. Effectors generated were then split and cultured 
with  either IL-2 plus anti-lL-4 or IL-2 plus different doses of IL-4 as 
shown in the figure. On day 10, cells were washed and stinmlated (2 ￿ 
lff'/ml) with Con A (5 ~g/ml) for 24 h for cytokine synthesis. 
CD4 + Thl and CD8 + TC1  cells were generated by stimu- 
lating normal splenic C57BL/6 CD4 + or CD8 + T  cells with 
allogeneic M12.4.1  cells in the presence of IL-2 plus IL-12 
plus anti-IL-4 for 7  d.  Cultures  were  then split and incu- 
bated with either IL-2 plus anti-IL-4 or IL-2 plus IL-4. Af- 
ter 3 more days, cells were washed and stimulated with Con 
A  for 24 h for cytokine synthesis. Fig. 10 demonstrates that 
IL-4 inhibited the IL-2-synthesizing ability of CD4 +  Thl 
cells, but loss of IL-2 synthesis was only partial, even at  10 
ng/ml IL-4. CD8 + TC1  cells were more susceptible, show- 
ing complete loss of [L-2 synthesis in response to  />2  ng/ 
ml of IL-4. 
Both IL-2 + and IL-2-  TCt Cells Are Highly Cytolytic.  To 
determine whether  the loss of IL-2-synthesizing ability of 
TC1  cells would alter their functions, we analyzed the cy- 
tolytic activity of IL-2  +  and  IL-2-  TC1  cells  toward  la- 
beled allogeneic tumor cell lines. 6 d after the generation of 
TC1  cells in IL-2 plus anti-IL-4, the cultures were split and 
the cells were stimulated for another 6 d with M12.4.1  cells 
in  the  presence  of (a)  IL-2  plus  anti-IL-4,  (b)  IL-2  plus 
IL-12 plus anti-IL-4, or (c) IL-2 plus IL-4. On day 12, cells 
were harvested to analyze their cytolytic ability and  cyto- 
kine production. Fig. 11  a confirms that cells grown in the 
presence of IL-4 do not synthesize IL-2, whereas the cells 
grown  in  anti-IL-4  or  IL-12  plus  anti-IL-4  remained 
IL-2+IFN-~/+. TC1  cells grown in all three growth condi- 
tions were cytolytic toward allogeneic (P815)  but not syn- 
geneic  (EL4)  targets  (Fig.  11  b).  The  cytotoxicity of the 
IL-2-  cells was  equal  to  that  of the  IL-2  +  cells grown  in 
IL-12, suggesting that  IL-2 synthesis does not affect cyto- 
toxicity. 
Loss of lL-2  Synthesis Impairs Autonomous ProloCeration of 
TC1  Cells.  We  tested whether  the lack of IL-2-synthe- 
sizing ability would render TC1  cells incapable of antigen- 
dependent  proliferation. IL-2  +  and  IL-2-  TC1  cells (Fig. 
12  a)  were stimulated with irradiated allogeneic J774  cells 
in  the  presence  or  absence  of different  concentrations  of 
IL-2 and IL-4. As a measure of proliferation, DNA synthe- 
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Figure  11.  IL-4-derived CD8 +  TC1  cells that secrete IFN-~/ but not 
1L-2 are highly cytolytic. C57BL/6 spleen CD8 + T  cells were stimulated 
with M12.4.1  cells  in the presence of IL-2 plus anti-IL-4 for 6  d.  TC1 
cells generated were then split and restimulated with allogeneic M12.4.1 
cells in the presence of IL-2 plus anti-lL-4, IL-2 plus IL-12 plus anti-IL-4, 
and IL-2 plus IL-4. On day 12, aliquots of TC1 cells were analyzed for (a) 
cytokine secretion after Con A stimulation for 24 h, and (b) cytotoxicity 
against SlCr-labeled P815 (allogeneic) and EL4 (syngeneic) cells. 
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Figure 12.  Exogenous cytokines are required to correct the proliferative 
defect in IL-2-  TC1  cells.  Allospecific (C57BL/6  CD8 +  anti-J774A.1) 
IL-2  § and IL-2- TC1 cells were generated as described in Fig. 1. On day 
12, TC1  cells (1.1  ￿  104/ml) were restimulated with irradiated J774A.1 
cells (5 ￿  104/ml) in the presence or absence of various growth factors for 
up to 4 d. Radiolabeled thymidine was added (1  txCi/well) at the same 
time or after every 24 h. Cells were then harvested 24 h after the thymi- 
dine pulse, and radioactive incorporation was determined by liquid scin- 
tillation counting. 
sis  was  then  assessed  by  analyzing  the  incorporation  of 
labeled thymidine every day for up to 4 d.  Fig.  12 b dem- 
onstrates that  in the absence of any exogenous cytokines, 
IL-2- and IL-2  + TC1  cells proliferated to a similar degree 
for the first day after antigen  stimulation,  whereas at later 
times proliferation continued  in the  IL-2  + population but 
declined rapidly in the IL-2- cells.  Addition of exogenous 
growth  factors  slightly  enhanced  proliferation  of  IL-2  + 
TC1  cells at day 4, presumably because the cells had used 
up the  IL-2 synthesized during the initial stimulation.  On 
the  other  hand,  exogenous  IL-2  strongly  enhanced  the 
proliferation of the IL-2- TC1  cells, and, at 1.5  ng/ml, al- 
most completely restored proliferation to the levels of IL- 
2 + cells.  IL-4 also enhanced proliferation of IL-2- cells but 
did not  fully restore proliferation even at  15  ng/ml.  The 
combination oflL-2 (0.5  ng/ml) and [L-4 (15 ng/ml) fully 
restored  proliferation  of the  [L-2-  cells.  Thus,  antigen- 
stimulated IL-2- TC1  cells  remained responsive to T  cell 
growth  factors  but  were  dependent  on  the  provision  of 
these cytokines from other sources. 
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Discussion 
Antigen stimulation of naive CD4 + and CD8 + T  cells in 
the presence oflL-12 and/or IFN-~/induces differentiation 
into the committed Thl and TC1 phenotypes, both secret- 
ing IL-2 and IFN-% However, long-term Thl clones often 
lose the ability to synthesize IL-2 while retaining IFN-~/syn- 
thesis  (2).  Among short-term CD8 +  clones,  some do not 
synthesize  IL-2 even when  first tested  (4,  44),  suggesting 
that CD8 + T  cells may more rapidly lose the ability to syn- 
thesize IL-2. We now show that IL-4 rapidly induced com- 
mitted TC1 cells to lose their subsequent ability to synthe- 
size  IL-2 but not IFN-% GM-CSF, or TNF.  Synthesis of 
IL-2 by Thl clones was also reduced by IL-4, although this 
required higher IL-4 concentrations, and complete loss was 
not observed. These results raise the possibility that endog- 
enous  IL-4  production  by  APC  might  account  for  the 
eventual loss of IL-2 synthesis by long-term clones. 
The mechanism of action oflL-4 on TC1 cells is not yet 
clear.  IL-4-induced inhibition  of IL-2-synthesizing ability 
occurs rapidly, within 24 h  of IL-4 treatment, even in the absence  of APC.  This  proves  that  IL-4  acts  directly  on 
TC1  cells  to impair  their  subsequent  ability  to synthesize 
IL-2. The  IL-2  +  --+ IL-2- transition  occurred when TC1 
cells  were  treated  with  IL-4 during  the  resting  phase,  or 
during  stimulation  with  either  M12.4.1  (B  cell-like)  or 
J774  (macrophage-like)  APC lines.  This  suggests  that  the 
IL-4  effect  cannot  be  prevented  by  costimulatory  signals 
supplied by these potent APC. Once established,  the IL-2- 
phenotype cannot be reversed by stimulation with APC in 
the presence or absence of IL-2, or by activation with anti- 
CD3 and anti-CD28.  Several mechanisms may account for 
the  IL-4 effect: Direct  modification  of the  IL-2 gene,  for 
example, by methylation, may result in long-term inactiva- 
tion.  IL-4 may permanently alter expression of some of the 
factors  that  bind  to  the  regulatory  elements  in  the  IL-2 
gene promoter (45). A long-term, selective alteration in IL-2 
messenger 1KNA processing or translation may be induced. 
Finally,  IL-4 may prevent  the  expression  of a  component 
of the  signaling  pathways,  particularly  in  the  B7-CD28/ 
CTLA4 pathway, which provides an essential costimulatory 
signal required for T  cell stimulation, especially for IL-2 pro- 
duction  (46). Expression of CD28 itself is similar on IL-2- 
and  IL-2  +  TC1  cells,  but  CTLA4 expression  or a  subse- 
quent step in the signaling pathway may be altered. 
During  stimulation  of naive  T  cells,  IL-4  inhibits  the 
generation  of cells  secreting the  Thl/TC1  pattern  of cy- 
tokines and induces the appearance of cells that secrete the 
Th2/TC2 pattern  (4,  6,  18,  19). IL-4 also inhibits the syn- 
thesis of IL-2 by naive CD4 + T  cells  in short-term culture 
(47).  These  effects  are  distinct  from our  current  observa- 
tion, as IL-4 induces naive cells  to switch to the TC2 phe- 
notype,  whereas  TC1  cells  only lose the ability  to secrete 
IL-2 but do not show other changes.  In both cases,  how- 
ever,  IL-4  induces  differentiation  rather  than  short-term 
modulation,  as  neither  the  naive  CD8 +  --+ TC2  nor  the 
IL-2  +  TC1  --+ IL-2-  TC1  transitions  are  reversible.  The 
effects  of  IL-4  on  naive  and  committed  cells  may  be 
brought  about  by different  mechanisms,  as  IL-4-induced 
differentiation  of naive  CD8 +  T  cells  into  TC2  cells  in- 
volves loss of IL-2 production accompanied by permanent 
alteration  of  the  synthesis  of  several  other  cytokines, 
whereas the IL-2  + TC1 ---> IL-2- TC1 transition appears to 
be very selective, involving only the IL-2 gene. 
When CD4 + Thl  cells are stimulated in the presence of 
fixed APC or anti-CD3 antibodies, they selectively lose the 
ability  to  synthesize  IL-2  and  proliferate,  while  retaining 
cytotoxicity, secretion  of other cytokines, and responsive- 
ness to IL-2 (27, 28). This state has been referred to as "an- 
ergy," although anergy previously meant a lack of effector 
function rather than a selective loss of autonomous prolifer- 
ation.  Most experiments  on the  induction  of anergy have 
focused on CD4 +  cells,  but a similar state  can be induced 
by stimulation  of CD8 + cells with fixed APC  (29).  These 
conditions  allow  TC1K engagement  in  the  absence  of the 
crucial second (costimulatory) signal mediated by APC. Al- 
though  anergic  CD4 +  cells  are  unable  to  synthesize  IL-2 
and proliferate autonomously, they remain fully antigen re- 
sponsive, as assessed  by the synthesis of other cytokines. In 
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contrast  to  the  important  rote  of costimulatory  signals  in 
previous reports on the induction or prevention of anergy, 
our results  show that  the  IL-2- state  of TCl  ceils  can be 
induced by IL-4 in the presence or absence of TCR  or co- 
stimulatory signals.  Although the mechanisms of induction 
are distinct, it is still possible that the IL-2- TC1 ceils gen- 
erated in the presence of IL-4 are equivalent to the "aner- 
gic" T  cells  derived  by stimulation  in  the  absence  of co- 
stimulatory signals. 
The  state  of anergy in  CD4 +  cells  can  be  reversed  by 
stimulation  with  allogenic  non-T  cells  and  IL-2 in  some 
systems (30, 31) but not others (33).  Our results clearly in- 
dicate that IL-4-induced loss of IL-2-synthesizing ability in 
TCl  CD8 + cells occurs even in the presence of excess IL-2 
and is not reversed by stimulation  in the presence of anti- 
CD28 antibodies,  or by continued culture with IL-2, even 
with potent APC and anti-IL-4 antibodies. 
The requirements for costimulation and the induction of 
anergy  may  be  different  for  CD4  +  and  CD8 +  T  cells. 
CD4 +  cells  are stimulated  by MHC  class  II  +  cells,  which 
are often APC with strong costimulatory functions such as 
dendritic cells,  B cells,  and macrophages. In contrast, CD8 + 
cells can potentially recognize antigen on almost any nucle- 
ated cell, and so will often be stimulated with antigen/MHC 
in  the  absence  of costimulation.  Also,  CD8 +  effector  T 
cells kill targets rapidly, so that there is little opportunity for 
the target cell to up-regulate expression of costimulators as 
occurs  during  CD4-APC  interaction.  Thus,  CD8 +  cells 
may require less costimulation than CD4 + cells,  consistent 
with a report that fibroblasts can stimulate an efficient CD8 + 
response  (48),  although  IL-2 synthesis  was  not  measured. 
However, some requirement for costimulation is indicated 
by the ability of fixed APC to induce anergy in CD8 + ceils 
(29).  Another  difference  between  CD4 +  and  CD8 +  ceils 
may relate to sensitivity to IL-4. Human CD4 + cells can be 
anergized  by APC  lacking  costimulators,  and  this  is  pre- 
vented by IL-4 (32).  In contrast, our studies on mouse CD8 + 
cells  demonstrate that they are "anergized" by IL-4. 
Both the  IL-2  + and  IL-2- TC1  cells  were highly cyto- 
toxic  when  cultured  in  IL-12  and  IL-4,  respectively. 
Therefore,  IL-2 secretion by a T  cell during the  effector- 
target  interaction  does  not  appear  to  affect  cytotoxicity. 
Similarly,  cytotoxicity  was  retained  by  both  CD4 +  and 
CD8 + anergic T  cells  lacking IL-2-synthesizing ability in- 
duced by fixed APC (29, 49).  In contrast to their ability to 
kill  target  cells  and  synthesize  other  cytokines,  TCl  ceils 
that lacked IL-2-synthesizing ability were unable to prolif- 
erate when stimulated in the absence of exogenous growth 
factors.  Proliferation was restored by the  addition  of IL-2, 
and to a lesser extent by IL-4. Thus, CD8 + TC1 cells lack- 
ing IL-2~ynthesizing ability appear to retain short-term el- 
lector function  (cytotoxicity)  while  losing  their  ability  to 
proliferate autonomously. 
Thus, the loss oflL-2 production by TC1 cells may have 
more effect on clonal expansion than on effector functions. 
If TC1  responses  coexist  with  Th2  or  TC2  responses  in 
vivo, TC1  cells  might lose their ability to secrete  IL-2 be- 
cause  of local  IL-4 secretion.  This  may impair  clonal  ex- 
Synthesis by CD8 + TC1 Cells pansion of the TC1  cells, as they would now be dependent 
on  T  cell growth  factors produced by other cells, such  as 
IL-2 and IL-4 produced by other T  cells or IL-15 produced 
by nonlymphoid  cells such  as muscle  cells,  fibroblasts, or 
monocytes  (50).  Because  of these  other sources  of T  cell 
growth factors in vivo, anergic T  cells may show damping 
of responses  in  vivo  in  contrast  to  the  abrogation  of re- 
sponses seen in tissue culture systems that lack many of the 
cell types that contribute to in vivo responses. 
The induction of the TC1  IL-2- phenotype by IL-4 is 
consistent with other mechanisms whereby type 1 and type 
2  responses cross-regulate each other.  IL-10 and IL-4 pro- 
duced by Th2 or TC2 cells inhibit IFN-~/synthesis and dif- 
ferentiation of Thl and TC1  cells (4,  18, 21, 22, 51). Con- 
versely, IFN-~/secreted by Thl  and TC1  cells inhibits the 
proliferation of Th2 cells (23, 24).  Our results now suggest 
that Th2 and TC2  cells, via production of IL-4, may limit 
the  extent of a  TC1  response by preventing autonomous 
expansion in the absence of growth factors from other cells, 
but maintaining short-term effector functions. 
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